[go: up one dir, main page]

ECSP077126A - Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores - Google Patents

Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores

Info

Publication number
ECSP077126A
ECSP077126A EC2007007126A ECSP077126A ECSP077126A EC SP077126 A ECSP077126 A EC SP077126A EC 2007007126 A EC2007007126 A EC 2007007126A EC SP077126 A ECSP077126 A EC SP077126A EC SP077126 A ECSP077126 A EC SP077126A
Authority
EC
Ecuador
Prior art keywords
propulsing
aerosol
formulations
suspension
agents
Prior art date
Application number
EC2007007126A
Other languages
English (en)
Inventor
Christel Schmelzer
Arne Froemder
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP077126(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032322A external-priority patent/DE102004032322A1/de
Priority claimed from DE200510023334 external-priority patent/DE102005023334A1/de
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of ECSP077126A publication Critical patent/ECSP077126A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a formulaciones de gases propulsores que contienen al menos un principio activo suspendido, el cual contiene agua unida químicamente, agua y el agente propulsor TG 227 o TG 134 a.
EC2007007126A 2004-07-02 2007-01-02 Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores ECSP077126A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE200510023334 DE102005023334A1 (de) 2005-05-17 2005-05-17 Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Publications (1)

Publication Number Publication Date
ECSP077126A true ECSP077126A (es) 2007-02-28

Family

ID=35169696

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007126A ECSP077126A (es) 2004-07-02 2007-01-02 Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores

Country Status (19)

Country Link
US (1) US8357352B2 (es)
EP (1) EP1809243B2 (es)
JP (1) JP5209963B2 (es)
KR (1) KR101297061B1 (es)
AR (1) AR049660A1 (es)
AU (1) AU2005259523B2 (es)
BR (1) BRPI0512878A (es)
CA (1) CA2571519C (es)
DK (1) DK1809243T4 (es)
EA (1) EA013428B1 (es)
EC (1) ECSP077126A (es)
ES (1) ES2391563T5 (es)
IL (1) IL180461A0 (es)
MX (1) MXPA06015204A (es)
NO (1) NO20070373L (es)
NZ (1) NZ552869A (es)
PL (1) PL1809243T5 (es)
TW (1) TWI377943B (es)
WO (1) WO2006002840A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2571519C (en) 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB2442745B (en) 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
GB2442746B (en) 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US8389021B2 (en) * 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
ES2957901T3 (es) 2014-05-07 2024-01-29 Boehringer Ingelheim Int Recipiente y dispositivo indicador y nebulizador
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
US10322198B2 (en) 2016-07-08 2019-06-18 The Procter & Gamble Company Freshening compositions comprising isopropyl myristate
BR112021001731A2 (pt) 2018-07-31 2021-04-27 Microbion Corporation composições de bismuto-tiol e métodos de uso

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9202519D0 (en) † 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
ES2129117T3 (es) 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
ES2140943T3 (es) 1993-04-30 2000-03-01 Minnesota Mining & Mfg Configuracion de cierre hermetico para botes de aerosol.
WO1995002651A1 (en) 1993-07-15 1995-01-26 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
JP3573213B2 (ja) 1995-04-14 2004-10-06 グラクソ、ウェルカム、インコーポレーテッド ベクロメタゾンジプロピオネート用計量投与用吸入器
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
JP3801348B2 (ja) 1997-07-28 2006-07-26 株式会社ヴァレオサーマルシステムズ レシーバタンク
JP4117059B2 (ja) * 1998-02-10 2008-07-09 東洋エアゾール工業株式会社 高濃度粉末エアゾール製品
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
CN1150890C (zh) 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
US5955958A (en) † 1998-10-05 1999-09-21 Lu; Kai Holiday candy jar with light and sound effects
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6739333B1 (en) * 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
WO2002005785A1 (en) * 2000-07-18 2002-01-24 Aeropharm Technology Incorporated Modulated release therapeutic aerosols
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
AU2002322314B2 (en) 2001-06-26 2006-08-17 Norton Healthcare, Ltd. An improved aerosol actuator
JP2005530686A (ja) 2002-02-01 2005-10-13 アストラゼネカ・アクチエボラーグ 吸入組成物
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
HUE049426T2 (hu) 2002-03-01 2020-09-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
DE10214263A1 (de) † 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ATE422197T1 (de) 2002-11-22 2009-02-15 Lilly Co Eli Modulatoren von vitamin d rezeptoren
CA2519523C (en) * 2003-03-20 2012-03-13 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
AR041873A1 (es) † 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
DE102004032322A1 (de) 2004-07-02 2006-02-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
CA2571519C (en) 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
CA2591406A1 (en) 2004-12-17 2006-06-22 Cipla Limited Pharmaceutical compounds and compositions
DE102006053374A1 (de) 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
US8357352B2 (en) 2013-01-22
EA200700042A1 (ru) 2007-08-31
NZ552869A (en) 2010-06-25
KR101297061B1 (ko) 2013-08-19
TWI377943B (en) 2012-12-01
CA2571519C (en) 2013-05-14
AR049660A1 (es) 2006-08-23
AU2005259523A1 (en) 2006-01-12
DK1809243T4 (da) 2022-09-05
US20060002863A1 (en) 2006-01-05
EP1809243B2 (de) 2022-06-08
EA013428B1 (ru) 2010-04-30
WO2006002840A3 (de) 2006-11-16
NO20070373L (no) 2007-01-31
EP1809243B8 (de) 2013-02-27
CA2571519A1 (en) 2006-01-12
PL1809243T5 (pl) 2022-12-27
WO2006002840A2 (de) 2006-01-12
AU2005259523B2 (en) 2011-06-09
JP5209963B2 (ja) 2013-06-12
ES2391563T3 (es) 2012-11-27
EP1809243A2 (de) 2007-07-25
DK1809243T3 (da) 2012-10-15
ES2391563T5 (es) 2022-10-26
PL1809243T3 (pl) 2013-05-31
JP2008504325A (ja) 2008-02-14
MXPA06015204A (es) 2007-03-15
WO2006002840A8 (de) 2012-11-08
KR20070042166A (ko) 2007-04-20
TW200612945A (en) 2006-05-01
IL180461A0 (en) 2007-06-03
BRPI0512878A (pt) 2008-04-15
EP1809243B1 (de) 2012-07-18

Similar Documents

Publication Publication Date Title
ECSP077126A (es) Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores
BRPI0413922A (pt) xantinas de 8-heteroarila substituìda
AR058502A1 (es) Composiciones azeotropicas que comprenden e - 1,3,3,3 tetrafluoropropeno y fluoruro de hidrogeno y sus usos
SV2006002215A (es) Nuevos herbicidas ref. 70471/sv
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
GT200500159A (es) (orto-fenil)-anilidas de àcido 1-metil-3-trifluorometil-pirazol-4-carboxìlico y su uso como fungicida
CR9846A (es) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas
TW200700406A (en) Novel thiophene derivatives
ATE469163T1 (de) Phosphonat prodrogen von einem analog des 2'- fluoro-2',3'-didehydro-2',3'-dideoxyadenosins als anti-hiv mittel
IL211085A0 (en) Perfusion solution
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
CR8428A (es) Agente endoparasiticidas para la administracion topica
GB0421900D0 (en) Inhibition of tumour cell migration
MX2009003378A (es) Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos.
IL182378A0 (en) House, more particularly an emergency house
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
AR110174A2 (es) Agentes endoparasiticidas y procedimiento de preparación
BRPI0403461A (pt) composições estabilizadas contendo um agente ativo lábil ao oxigênio
TR200902923T2 (tr) Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida
ITRM20040607A1 (it) Analoghi della dermorfina ad attivita' analgesica.
CR8820A (es) Nueva asociacion de un inhibidor de la corriente sinusual l1t y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen.
AR048826A1 (es) Composiciones antitranspirantes
MA29105B1 (fr) Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique